Both DPP-4 inhibitors and GLP-1 RAs have demonstrated safety in robust cardiovascular outcome trials, while several GLP-1 RAs have been shown to significantly reduce the risk of major adverse cardiovascular events in persons with T2DM with pre-existing cardiovascular disease (CVD)
Wei X, Xie F, Zhou X, Wu Y, Yan H, Liu T, et al
All equipment was wiped with 80% ethanol before and between each test mouse to remove olfactory cues
Mark Hyman outlines the principles of functional medicine, an integrative systems approach that views the body's systems as interconnected
[DOI] [PMC free article] [PubMed] [Google Scholar] 78.Rossignol DA, Genuis SJ, Frye RE